Ovid Therapeutics Inc. (OVID): Valuation
TTM figures as of June 30, 2026
Ovid Therapeutics Inc. trades at a -10.43% free-cash-flow yield. That FCF yield is higher than 85% of its own month-end history back to 2017.
Earnings yield -6.57%.
112 month-end valuation observations are on file, starting May 2017.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is OVID cheap versus its own history?
Ovid Therapeutics Inc. trades at a -10.43% free-cash-flow yield. That FCF yield is higher than 85% of its own month-end history back to 2017.
What is OVID's free-cash-flow yield?
Ovid Therapeutics Inc. currently yields -10.43% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.